Glucocorticoids remain the mainstay of treatment of giant cell arteritis. The aim of this review is to establish the optimal schedule of glucocorticoid administration, and to ascertain which other treatments may be used as glucocorticoid-sparing agents.
Improving therapeutic options for patients with giant cell arteritis / Pipitone, Nicolò; Salvarani, Carlo. - In: CURRENT OPINION IN RHEUMATOLOGY. - ISSN 1040-8711. - 20:1(2008), pp. 17-22. [10.1097/BOR.0b013e3282f31769]
Improving therapeutic options for patients with giant cell arteritis
SALVARANI, CARLO
2008
Abstract
Glucocorticoids remain the mainstay of treatment of giant cell arteritis. The aim of this review is to establish the optimal schedule of glucocorticoid administration, and to ascertain which other treatments may be used as glucocorticoid-sparing agents.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
